Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hogan

Showing results (411-420 of 484) with videos related to

Pageof 49
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|December 4, 2019
Epidemiology of Autosomal Dominant Polycystic Kidney Disease in Olmsted CountyTatsuya Suwabe, Shehbaz Shukoor, Alanna M Chamberlain, et al.
Journal of Medicinal Chemistry|December 14, 2011
Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacyRoger B Clark, Diana K Hunt, Minsheng He, et al.
Journal of the American Society of Nephrology : JASN|May 1, 2010
Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver diseaseMarie C Hogan, Tetyana V Masyuk, Linda J Page, et al.
Kidney360|July 7, 2025
Pain Management in Autosomal Dominant Polycystic Kidney Disease: Clinical Challenges and a Stepwise Algorithmic ApproachAbdul Hamid Borghol, Fadi George Munairdjy Debeh, Ahmad Ghanem, et al.
Carcinogenesis|December 1, 2021
Functional assessment of somatic STK11 variants identified in primary human non-small cell lung cancersLiam L Donnelly, Tyler C Hogan, Sean M Lenahan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 27, 2020
Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement: A Randomized Clinical TrialMarie C Hogan, Julie A Chamberlin, Lisa E Vaughan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 31, 2020
CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018Jennifer S Lee, Elizabeth A Humes, Brenna C Hogan, et al.
Kidney International Reports|March 18, 2021
Characteristics of Patients with End-Stage Kidney Disease in ADPKDShehbaz S Shukoor, Lisa E Vaughan, Marie E Edwards, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 21, 2018
Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney DiseaseMarie E Edwards, Fouad T Chebib, Maria V Irazabal, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 14, 2010
Rituximab therapy in idiopathic membranous nephropathy: a 2-year studyFernando C Fervenza, Roshini S Abraham, Stephen B Erickson, et al.
Pageof 49

Showing results (411-420 of 484) with videos related to

Sort By:
Pageof 49
Clinical Journal of the American Society of Nephrology : CJASN|December 4, 2019
Epidemiology of Autosomal Dominant Polycystic Kidney Disease in Olmsted CountyTatsuya Suwabe, Shehbaz Shukoor, Alanna M Chamberlain, et al.
Journal of Medicinal Chemistry|December 14, 2011
Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacyRoger B Clark, Diana K Hunt, Minsheng He, et al.
Journal of the American Society of Nephrology : JASN|May 1, 2010
Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver diseaseMarie C Hogan, Tetyana V Masyuk, Linda J Page, et al.
Kidney360|July 7, 2025
Pain Management in Autosomal Dominant Polycystic Kidney Disease: Clinical Challenges and a Stepwise Algorithmic ApproachAbdul Hamid Borghol, Fadi George Munairdjy Debeh, Ahmad Ghanem, et al.
Carcinogenesis|December 1, 2021
Functional assessment of somatic STK11 variants identified in primary human non-small cell lung cancersLiam L Donnelly, Tyler C Hogan, Sean M Lenahan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 27, 2020
Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement: A Randomized Clinical TrialMarie C Hogan, Julie A Chamberlin, Lisa E Vaughan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 31, 2020
CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018Jennifer S Lee, Elizabeth A Humes, Brenna C Hogan, et al.
Kidney International Reports|March 18, 2021
Characteristics of Patients with End-Stage Kidney Disease in ADPKDShehbaz S Shukoor, Lisa E Vaughan, Marie E Edwards, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 21, 2018
Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney DiseaseMarie E Edwards, Fouad T Chebib, Maria V Irazabal, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 14, 2010
Rituximab therapy in idiopathic membranous nephropathy: a 2-year studyFernando C Fervenza, Roshini S Abraham, Stephen B Erickson, et al.
Pageof 49